Effect of Drug Software on Drug Interactions

Effect of Using Drug Software on Drug Interactions in ICU

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190120042433N1

Enrollment

138

Registered

2019-02-18

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug interactions.

Interventions

Intervention 1: Intervention group: Intervention involves the use of researcher-made software for the registration and review of prescribed medications for samples. In the intervention group, the drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Use more than one drug category for the patient Patient being hospitalized for at least 3 days in ICU

Exclusion criteria

Exclusion criteria: Discharge or the death of patient earlier than 3 days

Design outcomes

Primary

Measure	Time frame
Drug interactions. Timepoint: Measurement of the incidence of drug interactions at the same time as the drug is registered in the software and its continuous review during at least 3 days of patients hospitalization in the ICU. Method of measurement: Drug interactions check list.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Idani

Ahvaz University of Medical Sciences

maryamidani@yahoo.com+98 61 3338 4754

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026